ADMA Biologics faces class action after March 2026 stock drops

Bleichmar Fonti & Auld said investors have until August 10, 2026 to seek lead plaintiff status in a New Jersey case tied to allegations of channel stuffing and undisclosed related party transactions.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.